And reputational cost. We wonder why the ASX doesn't rate us as we think it should and broking firms won't research us - it's because of our history of not delivering. I thought we were past that with new management.
Shareholders were told at the last quarterly update April for first dosing. Then we were copied on a presentation to be delivered in the USA that May was first dosing. Now we hear via a discussion with a members only investment media company that it's first patient enrolled in May - not dosed. I get it that there are lots of variables at play but please talk to us - don't continue with movable deadlines with no discussion.
Valuing PYC, page-79
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 12.0¢ | $185.3K | 1.515M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 166662 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 39575 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PYC (ASX) Chart |